Ekso bionics announces closing of $40 million bought deal offering

Richmond, calif., feb. 11, 2021 (globe newswire) -- ekso bionics holdings, inc. (nasdaq: ekso) (“ekso bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced the closing of its previously announced underwritten public offering of 3,902,440 shares of common stock of ekso bionics, at a price to the public of $10.25 per share, less underwriting discounts and commissions. as previously announced, ekso bionics also has granted to the underwriter a 30-day option to purchase up to an additional 585,366 shares of common stock at the public offering price, less underwriting discounts and commissions.
EKSO Ratings Summary
EKSO Quant Ranking